Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : 2013 Biotech Charity Contest -- Ignore unavailable to you. Want to Upgrade?

To: BulbaMan who wrote (144)	1/18/2013 8:21:01 PM
From: nigel bates	Read Replies (1) \| Respond to of 410

As ever, thanks for your efforts ! On the subject of choosing a charity, this is a very interesting site, with some impressive analysis: givewell.org

To: BulbaMan who wrote (144)	1/19/2013 11:56:01 AM
From: mcbio	Read Replies (1) \| Respond to of 410

Bulba, interesting on PRTA. I think what you say makes a lot of sense in terms of the initial decline. I have them on my watchlist now. Like that they are a spin-out from ELN (makes me assign more credibility) rather than some small-cap biotech I've never heard of that doesn't have much of a track record. Do you know when they expect to enter the clinic? Which of their programs are you most excited about?

To: BulbaMan who wrote (144)	1/25/2013 5:20:41 PM
From: BulbaMan	4 Recommendations Read Replies (1) \| Respond to of 410

1/18/13 Contest Update Another iBad week for Apple held back the Nasdaq Composite Index, but biotech Bears remained in hibernation. At Friday’s close, the Contest median was up 6.17% YTD (vs. up 5.94% YTD a week ago), while the Nasdaq Biotech Index was up 6.60% (vs. up 5.54% YTD a week ago). And even with the Apple drag, the Nasdaq Composite Index finished the week up 4.31% YTD (vs. up 3.82% YTD a week ago). How does he do it? RKRW’s portfolio took the the Contest lead with a 23.93% YTD gain. But No. 2, MOPGCW’s portfolio, up 22.50% YTD, and No. 3, FILO’s portfolio, up 22.30% YTD, are both well within striking distance. At Friday's close, 35 of the 39 Contest portfolios were in the black with 18 of the 39 beating the NBI. Below is the Top Ten list. Also below are the Top 5 & Bottom 5 Stocks ranked by % Gained and % Lost YTD (foreign stock prices are not converted to US$ in these two tables). Portfolio adjustments: None Enjoy January’s final weekend biotechies! (All corrections, especially adjustments for splits, greatly appreciated.) Peace & good health, Bulba 1/25/13 Rank Name Profit/Loss 1 RKRW 23,929 2 MOPGCW 22,495 3 FILO 22,303 4 ROBERT 20,745 5 ARTHUR 17,241 6 THEOX 16,068 7 PGO 15,043 8 NIGEL 14,673 9 BIOMAV 11,901 10 DNAJOE 11,816 Week's Top 5 Gainers Symbol 1/18/13 1/25/13 Wk.%chg. MAPP 15.58 24.75 58.86% KIPS 0.69 0.84 22.04% RVX.TO 2.00 2.40 20.00% ACAD 5.22 6.19 18.58% AMF.TO 0.33 0.39 16.67% Week's Worst 5 Losers Symbol 1/18/13 1/25/13 Wk.%chg. CUR.TO 0.45 0.390 -12.36% ARNA 9.77 8.710 -10.85% ONTY 2.19 1.970 -10.05% ABLX.BR 6.94 6.390 -7.93% ONCY 3.67 3.390 -7.63%